Tag: Polarix Phase III trial
FDA admits Roche’s application for Polivy in lymphoma treatment
The United States Food and Drug Administration (FDA) has accepted the supplemental biologics license application(sBLA) by Roche, a Swiss multinational healthcare company, for the...